CytomX Therapeutics (CTMX) Other Non-Current Assets (2014 - 2026)
CytomX Therapeutics (CTMX) posted Other Non-Current Assets of $31000.0 for Q1 2026, little changed on a QoQ basis from $31000.0 in Q4 2025, and down 96.98% year-over-year from $1.0 million in Q1 2025.
CytomX Therapeutics (CTMX) Other Non-Current Assets (2014 - 2026) Analysis & Trends
CytomX Therapeutics' Other Non-Current Assets history runs 13 years deep, the most recent figure standing at $31000.0 for Q1 2026.
- Quarterly Other Non-Current Assets fell 96.98% year-over-year to $31000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31000.0 (down 96.98% YoY) and the FY2025 annual result came in at $31000.0, down 96.98% from the prior year.
- Other Non-Current Assets was $31000.0 for Q1 2026 at CytomX Therapeutics, roughly flat from $31000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $1.0 million in Q1 2025 and bottomed at $31000.0 in Q4 2025.
- A 5-year average of $796235.3 and a median of $917000.0 in 2022 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets soared 1137.35% — and 2026, when it tumbled 96.98%.
- CytomX Therapeutics' Other Non-Current Assets stood at $917000.0 in 2022, then plunged by 90.95% to $83000.0 in 2023, then surged by 1137.35% to $1.0 million in 2024, then plunged by 96.98% to $31000.0 in 2025, then changed by 0.0% to $31000.0 in 2026.
- Business Quant data shows CTMX's Other Non-Current Assets at $31000.0 in Q1 2026, $31000.0 in Q4 2025, and $1.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 1.02 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 104.24 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.26 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 2.13 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 124.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 14.48 Mn |
| 10 | CytomX Therapeutics | 590.32 Mn | 243.61 Mn | - | 31,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31,000.00 |
| Dec 31, 2025 | 31,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.03 Mn |
| Sep 30, 2024 | 1.03 Mn |
| Jun 30, 2024 | 917,000.00 |
| Mar 31, 2024 | 917,000.00 |
| Dec 31, 2023 | 83,000.00 |
| Sep 30, 2023 | 917,000.00 |
| Jun 30, 2023 | 917,000.00 |
| Mar 31, 2023 | 917,000.00 |
| Dec 31, 2022 | 917,000.00 |
| Sep 30, 2022 | 917,000.00 |
| Jun 30, 2022 | 917,000.00 |
| Mar 31, 2022 | 917,000.00 |
| Dec 31, 2021 | 917,000.00 |
| Sep 30, 2021 | 917,000.00 |
| Jun 30, 2021 | 917,000.00 |